Higher SARS-CoV-2 spike antibody levels are associated with reduced risk of subsequent symptomatic and severe COVID-19: A real-world data study

Publication Value in Health

Real-world study links higher SARS-CoV-2 spike antibody levels to reduced risk of symptomatic and severe COVID-19, supporting antibody use in risk assessment.


Read the article